Notify me when Boxer Capital, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | $0 | -$2,037,780,820 | -$2,037,780,820 | 13F-HR | 14 Feb 2025, 16:45 | |
| Q3 2024 | 68 | $2,037,780,820 | +$109,571,345 | -$44,683,301 | +$64,888,044 | RVMD, TYRA, NUVL, BGNE, CYTK | 13F-HR | 14 Nov 2024, 16:38 |
| Q2 2024 | 61 | $1,898,904,676 | +$87,588,762 | -$61,215,750 | +$26,373,012 | RVMD, SWTX, CYTK, MRUS, TYRA | 13F-HR | 14 Aug 2024, 16:15 |
| Q1 2024 | 59 | $2,024,741,156 | +$286,512,480 | -$398,125,162 | -$111,612,682 | SWTX, CYTK, RVMD, TYRA, APLS | 13F-HR | 15 May 2024, 11:20 |
| Q4 2023 | 52 | $2,006,361,800 | +$115,052,286 | -$356,583,005 | -$241,530,719 | MRTX, CYTK, SWTX, RVMD, APLS | 13F-HR | 14 Feb 2024, 16:03 |
| Q3 2023 | 73 | $1,878,507,388 | +$158,730,666 | -$255,478,532 | -$96,747,866 | MRTX, RVMD, BGNE, TYRA, AKRO | 13F-HR | 14 Nov 2023, 16:18 |
| Q2 2023 | 79 | $2,156,238,000 | +$306,274,016 | -$323,702,894 | -$17,428,878 | RETA, APLS, RVMD, TYRA, SWTX | 13F-HR | 14 Aug 2023, 16:07 |
| Q1 2023 | 75 | $2,035,626,000 | +$245,344,761 | -$32,121,704 | +$213,223,057 | RXDX, RETA, BGNE, SRPT, APLS | 13F-HR | 15 May 2023, 16:15 |
| Q4 2022 | 71 | $1,851,751,508 | +$144,509,329 | -$104,467,453 | +$40,041,876 | RXDX, BGNE, CYTK, RVMD, MRTX | 13F-HR | 14 Feb 2023, 13:03 |
| Q3 2022 | 73 | $1,778,081,000 | +$159,403,948 | -$182,564,626 | -$23,160,678 | MRTX, CYTK, RXDX, SWTX, APLS | 13F-HR | 14 Nov 2022, 16:17 |
| Q2 2022 | 76 | $1,578,912,000 | +$45,209,693 | -$57,731,995 | -$12,522,302 | MRTX, CYTK, BGNE, RVMD, APLS | 13F-HR | 15 Aug 2022, 16:37 |
| Q1 2022 | 74 | $1,945,613,000 | +$279,450,469 | -$186,936,034 | +$92,514,435 | MRTX, SWTX, ITOS, BGNE, RVMD | 13F-HR | 16 May 2022, 16:15 |
| Q4 2021 | 70 | $2,513,192,000 | +$383,152,781 | -$529,553,209 | -$146,400,428 | MRTX, XBI, ITOS, BGNE, SWTX | 13F-HR | 14 Feb 2022, 16:05 |
| Q3 2021 | 87 | $2,863,332,000 | +$448,255,105 | -$306,497,056 | +$141,758,049 | MRTX, BGNE, SWTX, ITOS, TYRA | 13F-HR | 15 Nov 2021, 16:31 |
| Q2 2021 | 95 | $2,834,340,000 | +$213,507,000 | -$8,101,880 | +$205,405,120 | MRTX, BGNE, SWTX, ITOS, RVMD | 13F-HR | 16 Aug 2021, 16:16 |
| Q1 2021 | 85 | $2,911,102,000 | +$371,924,813 | -$307,821,202 | +$64,103,611 | MRTX, BGNE, RVMD, SWTX, ITOS | 13F-HR | 17 May 2021, 16:15 |
| Q4 2020 | 78 | $3,097,922,000 | +$427,542,461 | -$659,210,345 | -$231,667,884 | MRTX, BGNE, SWTX, ITOS, PMVP | 13F-HR | 16 Feb 2021, 16:31 |
| Q3 2020 | 75 | $2,893,710,000 | +$639,930,403 | -$309,872,180 | +$330,058,223 | IMMU, BGNE, MRTX, RVMD, ITOS | Restatement | 17 Nov 2020, 13:46 |
| Q2 2020 | 65 | $2,274,579,000 | +$237,099,674 | -$196,461,736 | +$40,637,938 | IMMU, MRTX, BGNE, ODTC, RVMD | 13F-HR | 14 Aug 2020, 16:32 |
| Q1 2020 | 61 | $1,449,885,000 | +$387,741,706 | -$196,931,248 | +$190,810,458 | MRTX, IMMU, BGNE, ODTC, RVMD | 13F-HR | 15 May 2020, 16:25 |
| Q4 2019 | 50 | $1,723,983,000 | +$304,746,389 | -$380,078,178 | -$75,331,789 | MRTX, IMMU, BGNE, ODTC, MDCO | 13F-HR | 14 Feb 2020, 16:30 |
| Q3 2019 | 48 | $1,371,278,000 | +$394,232,996 | -$637,137 | +$393,595,859 | ONCE, MRTX, BGNE, IMMU, ODTC | 13F-HR | 14 Nov 2019, 17:22 |
| Q2 2019 | 0 | $0 | $0 | $0 | $0 | New Holdings | 15 Aug 2019, 16:40 | |
| Q2 2019 | 35 | $1,143,236,000 | +$300,305,271 | -$87,464,347 | +$212,840,924 | MRTX, ODTC, BGNE, IMMU, ONCE | 13F-HR | 14 Aug 2019, 16:30 |
| Q1 2019 | 23 | $864,736,000 | +$203,171,568 | -$222,707,902 | -$19,536,334 | MRTX, BGNE, IMMU, ODTC, QURE | 13F-HR | 15 May 2019, 16:02 |
| Q4 2018 | 23 | $804,778,000 | +$224,575,924 | -$92,888,004 | +$131,687,920 | BGNE, SLDB, PTCT, WVE, MRTX | 13F-HR | 14 Feb 2019, 16:26 |
| Q3 2018 | 24 | $897,163,000 | +$66,700,092 | -$157,897,072 | -$91,196,980 | SLDB, BGNE, PTCT, WVE, MRTX | 13F-HR | 14 Nov 2018, 16:16 |
| Q2 2018 | 26 | $883,149,000 | +$223,847,497 | -$307,255,238 | -$83,407,741 | SLDB, BGNE, MRTX, PTCT, ODTC | 13F-HR | 14 Aug 2018, 17:23 |
| Q1 2018 | 32 | $935,104,000 | +$292,588,405 | -$26,100,935 | +$266,487,470 | AVXS, BGNE, PTCT, ESPR, ODTC | 13F-HR | 15 May 2018, 16:02 |
| Q4 2017 | 26 | $547,127,000 | +$176,674,543 | -$84,087,959 | +$92,586,584 | AVXS, ODTC, BGNE, ESPR, MGNX | 13F-HR | 14 Feb 2018, 16:54 |
| Q3 2017 | 30 | $439,173,000 | +$39,330,620 | -$73,877,141 | -$34,546,521 | AVXS, BGNE, CLVSQ, MGNX, MDCO | 13F-HR | 14 Nov 2017, 16:10 |
| Q2 2017 | 26 | $400,334,000 | +$60,486,643 | -$150,262,901 | -$89,776,258 | AVXS, CLVSQ, ESPR, MDCO, MGNX | 13F-HR | 14 Aug 2017, 16:32 |
| Q1 2017 | 30 | $424,216,000 | +$105,748,097 | -$7,715,681 | +$98,032,416 | AVXS, CLVSQ, MDCO, ESPR, BGNE | 13F-HR | 15 May 2017, 17:01 |
| Q4 2016 | 27 | $237,233,000 | +$74,288,032 | -$40,356,821 | +$33,931,211 | AVXS, CLVSQ, MDCO, BGNE, BPMC | 13F-HR | 14 Feb 2017, 17:07 |
| Q3 2016 | 27 | $202,367,000 | +$70,755,189 | -$13,498,426 | +$57,256,763 | CLVSQ, MDCO, BPMC, BGNE, SGEN | 13F-HR | 14 Nov 2016, 16:51 |
| Q2 2016 | 23 | $106,259,000 | +$28,919,013 | -$13,774,904 | +$15,144,109 | BGNE, BPMC, SGEN, INCY, REGN | 13F-HR | 15 Aug 2016, 16:46 |
| Q1 2016 | 22 | $102,188,000 | +$51,640,623 | -$30,351,660 | +$21,288,963 | MRTX, BPMC, BGNE, CPXX, SGEN | 13F-HR | 16 May 2016, 16:30 |
| Q4 2015 | 15 | $115,826,000 | $0 | $0 | $0 | MRTX, AQXP, BPMC, SGEN, KURA | 13F-HR | 16 Feb 2016, 16:30 |